* Aethlon Medical Inc AEMD.OQ AEMD.O is expected to show
no
change in quarterly revenue when it reports results on August
14 for the period ending January 1 0001
*
* LSEG's mean analyst estimate for Aethlon Medical Inc is
for a
loss of 31 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $3.85, above its last closing price of $0.31.
This summary was machine generated August 13 at 01:55 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)